You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Medtronic
Colorcon
Johnson and Johnson
Baxter

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

LEVOLET Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Levolet patents expire, and when can generic versions of Levolet launch?

Levolet is a drug marketed by Genus Lifesciences and is included in one NDA.

The generic ingredient in LEVOLET is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Drug patent expirations by year for LEVOLET
Recent Clinical Trials for LEVOLET

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dr. Reddy's Laboratories LimitedPhase 4
Dr. Reddy's Laboratories LimitedN/A

See all LEVOLET clinical trials

US Patents and Regulatory Information for LEVOLET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-001 Jun 6, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-007 Jun 6, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-004 Jun 6, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-012 Jun 6, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-008 Jun 6, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-002 Jun 6, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-003 Jun 6, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Medtronic
Mallinckrodt
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.